All Names: Ambrisentan,Volibris,Endobloc
Indications:pulmonary arterial hypertension (PAH)
Manufacturer:Cipla, India
Customs Clearance Procedure:If the customs requires the package for customs clearance, please pay the customs clearance fee according to the content of EMS SMS and customs regulations.
INDICATIONS AND USAGE(适应症)
Ambrisentan tablets are indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1):
To improve exercise ability and delay clinical worsening.
DOSAGE(服用剂量)
Adult Dosage
Initiate treatment at 5 mg once daily. At 4-week intervals, the dose of ambrisentan can be increased, as needed and tolerated to 10 mg.
Do not split, crush, or chew tablets.
Pregnancy Testing in Females of Reproductive Potential
Initiate treatment with ambrisentan tablets in females of reproductive potential only after a negative pregnancy test. Obtain monthly pregnancy tests during treatment.
ADVERSE REACTIONS(不良反应)
Embryo-fetal Toxicity
Fluid Retention
Pulmonary Edema with PVOD
Decreased Sperm Count
Hematologic Changes
For full information, please refer to:
https://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/37af3191-0ed3-4783-8747-065f1462f2d2/spl-doc?hl=Ambrisentan
Endoblocinformation
No information yet!!!